Consequently, regulating GzmB through Sb9 could represent a novel therapeutic strategy for preventing cardiovascular diseases, such as atherosclerosis, plaque rupture, and ventricular remodeling after acute myocardial infarction (AMI) (134). This evidence concerns the gene GZMB and atherosclerosis.